CATAPRESAN

This brand name is authorized in Austria, Germany, Estonia, Spain, Finland, Malta, Mexico, Netherlands

Active ingredients

The drug CATAPRESAN contains one active pharmaceutical ingredient (API):

1 Clonidine UNII W76I6XXF06 - CLONIDINE HYDROCHLORIDE

Clonidine has been shown to have both central and peripheral sites of action. With long-term treatment clonidine reduces the responsiveness of peripheral vessels to vasoconstrictor and vasodilator substances and to sympathetic nerve stimulation. Early in treatment, however, blood pressure reduction is associated with a central reduction of sympathetic outflow and increased vagal tone. Read about Clonidine

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
C02AC01	Clonidine	C Cardiovascular system → C02 Antihypertensives → C02A Antiadrenergic agents, centrally acting → C02AC Imidazoline receptor agonists
Discover more medicines within C02AC01
N02CX02	Clonidine	N Nervous system → N02 Analgesics → N02C Antimigraine preparations → N02CX Other antimigraine preparations
Discover more medicines within N02CX02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 01641379, 01641439, 02700782
Country: EE	Ravimiamet	Identifier(s): 1314289, 1702774, 1875832
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 50669
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 148833, 149484
Country: MT	Medicines Authority	Identifier(s): AA565/81401, AA565/81402
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 69039
Country: NL	Z-Index G-Standaard	Identifier(s): 12108804
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 1449